Does TOCILIZUMAB Cause Pulmonary mass? 401 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 401 reports of Pulmonary mass have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.4% of all adverse event reports for TOCILIZUMAB.
401
Reports of Pulmonary mass with TOCILIZUMAB
0.4%
of all TOCILIZUMAB reports
2
Deaths
102
Hospitalizations
How Dangerous Is Pulmonary mass From TOCILIZUMAB?
Of the 401 reports, 2 (0.5%) resulted in death, 102 (25.4%) required hospitalization, and 21 (5.2%) were considered life-threatening.
Is Pulmonary mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 401 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Pulmonary mass?
ADALIMUMAB (1,299)
METHOTREXATE (1,153)
PREDNISONE (755)
ALBUTEROL (736)
ETANERCEPT (665)
TIOTROPIUM (624)
RITUXIMAB (531)
BUDESONIDE\FORMOTEROL (464)
MEPOLIZUMAB (450)
LEFLUNOMIDE (430)
Which TOCILIZUMAB Alternatives Have Lower Pulmonary mass Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE